For: | Jan YY, Yeh CN, Yeh TS, Chen TC. Prognostic analysis of surgical treatment of peripheral cholangiocarcinoma: Two decades of experience at Chang Gung Memorial Hospital. World J Gastroenterol 2005; 11(12): 1779-1784 [PMID: 15793863 DOI: 10.3748/wjg.v11.i12.1779] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i12/1779.htm |
Number | Citing Articles |
1 |
Manousos M. Konstadoulakis, Sasan Roayaie, Ilias P. Gomatos, Daniel Labow, Maria-Isabell Fiel, Charles M. Miller, Myron E. Schwartz. Fifteen-year, single-center experience with the surgical management of intrahepatic cholangiocarcinoma: Operative results and long-term outcome. Surgery 2008; 143(3): 366 doi: 10.1016/j.surg.2007.10.010
|
2 |
Shao-Liang Han, Hong-Zhong Zhou, Jun Cheng, Sheng-Hong Lan, Pei-Chen Zhang, Zhe-Jing Chen, Qi-Qiang Zeng. Diagnosis and Surgical Treatment of Intrahepatic Hepatolithiasis Associated Cholangiocarcinoma. Asian Journal of Surgery 2009; 32(1): 1 doi: 10.1016/S1015-9584(09)60001-4
|
3 |
Gonzalo Sapisochín, Elena Fernández de Sevilla, Juan Echeverri, Ramón Charco. Liver transplantation for cholangiocarcinoma: Current status and new insights. World Journal of Hepatology 2015; 7(22): 2396-2403 doi: 10.4254/wjh.v7.i22.2396
|
4 |
Vor Luvira, Ake Pugkhem, Vajarabhongsa Bhudhisawasdi, Chawalit Pairojkul, Egapong Sathitkarnmanee, Varisara Luvira, Supot Kamsa‐ard. Long‐term outcome of surgical resection for intraductal papillary neoplasm of the bile duct. Journal of Gastroenterology and Hepatology 2017; 32(2): 527 doi: 10.1111/jgh.13481
|
5 |
Yufei Zhu, Yunhai Zhu, Feng Cai, Jie Zhao, Feng Liu. Prognostic Risk Factors Associated with Recurrence and Metastasis After Radical Resection in Patients with Hepatolithiasis Complicated by Intrahepatic Cholangiocarcinoma. Cell Biochemistry and Biophysics 2015; 73(2): 455 doi: 10.1007/s12013-015-0665-x
|
6 |
Ming-Liang Wang, Zhang-Yan Ke, Shuai Yin, Chen-Hai Liu, Qiang Huang. The effect of adjuvant chemotherapy in resectable cholangiocarcinoma: A meta-analysis and systematic review. Hepatobiliary & Pancreatic Diseases International 2019; 18(2): 110 doi: 10.1016/j.hbpd.2018.11.001
|
7 |
Sakda Waraasawapati, Raksawan Deenonpoe, Prakasit Sa-ngiamwibool, Yaovalux Chamgramol, Chawalit Pairojkul. Diagnosis and Management of Cholangiocarcinoma. 2021; : 265 doi: 10.1007/978-3-030-70936-5_11
|
8 |
H. Petrowsky, J.C. Hong. Current Surgical Management of Hilar and Intrahepatic Cholangiocarcinoma: The Role of Resection and Orthotopic Liver Transplantation. Transplantation Proceedings 2009; 41(10): 4023 doi: 10.1016/j.transproceed.2009.11.001
|
9 |
Ganapathy A. Prasad, Kenneth K. Wang, Todd H. Baron, Navtej S. Buttar, Louis–Michel Wongkeesong, Lewis R. Roberts, Andrew J. LeRoy, Lori S. Lutzke, Lynn S. Borkenhagen. Factors Associated With Increased Survival After Photodynamic Therapy for Cholangiocarcinoma. Clinical Gastroenterology and Hepatology 2007; 5(6): 743 doi: 10.1016/j.cgh.2007.02.021
|
10 |
D Tamandl, K Kaczirek, B Gruenberger, C Koelblinger, J Maresch, R Jakesz, T Gruenberger. Lymph node ratio after curative surgery for intrahepatic cholangiocarcinoma. British Journal of Surgery 2009; 96(8): 919 doi: 10.1002/bjs.6654
|
11 |
Parham Mafi, Quyen D. Chu, Richard R. Smith, John F. Gibbs. Surgical Oncology. 2015; : 257 doi: 10.1007/978-1-4939-1423-4_12
|
12 |
Hans Francis Schoellhammer, Yuman Fong, Gagandeep Singh. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set. 2017; : 818 doi: 10.1016/B978-0-323-34062-5.00051-0
|
13 |
W. F. Shen, W. Zhong, Q. Liu, C. J. Sui, Y. Q. Huang, J. M. Yang. Adjuvant Transcatheter Arterial Chemoembolization for Intrahepatic Cholangiocarcinoma after Curative Surgery: Retrospective Control Study. World Journal of Surgery 2011; 35(9): 2083 doi: 10.1007/s00268-011-1171-y
|
14 |
Vor Luvira, Supot Kamsa-ard, Siriporn Kamsa-ard, Varisara Luvira, Tharatip Srisuk, Ake Pugkhem, Chawalit Pairojkul, Vajarabhongsa Bhudhisawasdi. Association between Repeated Praziquantel treatment and Papillary, and Intrahepatic Cholangiocarcinoma. Annals of Hepatology 2018; 17(5): 802 doi: 10.5604/01.3001.0012.3140
|
15 |
Hani Jassim Alramadhan, Soo-Yeun Lim, Hye-Jeong Jeong, Hyun-Jeong Jeon, Hochang Chae, So-Jeong Yoon, Sang-Hyun Shin, In-Woong Han, Jin-Seok Heo, Hongbeom Kim. Different Oncologic Outcomes According to Margin Status (High-Grade Dysplasia vs. Carcinoma) in Patients Who Underwent Hilar Resection for Mid-Bile Duct Cancer. Cancers 2023; 15(21): 5166 doi: 10.3390/cancers15215166
|
16 |
Alfredo Guglielmi, Andrea Ruzzenente, Calogero Iacono. Surgical Treatment of Hilar and Intrahepatic Cholangiocarcinoma. Updates in Surgery 2008; : 233 doi: 10.1007/978-88-470-0729-1_23
|
17 |
Abbas Rana, Johnny C. Hong. Orthotopic liver transplantation in combination with neoadjuvant therapy. Current Opinion in Gastroenterology 2012; 28(3): 258 doi: 10.1097/MOG.0b013e32835168db
|
18 |
Sagar A. Patel, Florence K. Keane, Theodore S. Hong. Primary and Metastatic Liver Tumors. 2018; : 125 doi: 10.1007/978-3-319-91977-5_10
|
19 |
Tse-Ching Chen, Yi-Yin Jan, Ta-Sen Yeh. K-ras Mutation is Strongly Associated with Perineural Invasion and Represents an Independent Prognostic Factor of Intrahepatic Cholangiocarcinoma after Hepatectomy. Annals of Surgical Oncology 2012; 19(S3): 675 doi: 10.1245/s10434-012-2224-7
|
20 |
Soo Yeun Lim, Hani Jassim Alramadhan, HyeJeong Jeong, Hochang Chae, Hyeong Seok Kim, So Jeong Yoon, Sang Hyun Shin, In Woong Han, Jin Seok Heo, Hongbeom Kim. Survival Comparison of Different Operation Types for Middle Bile Duct Cancer: Bile Duct Resection versus Pancreaticoduodenectomy Considering Complications and Adjuvant Treatment Effects. Cancers 2024; 16(2): 297 doi: 10.3390/cancers16020297
|
21 |
Darren R. Carpizo, Michael D'Angelica. Management and Extent of Resection for Intrahepatic Cholangiocarcinoma. Surgical Oncology Clinics of North America 2009; 18(2): 289 doi: 10.1016/j.soc.2008.12.010
|
22 |
Sagar A. Patel, Florence K. Keane, Theodore S. Hong. Radiation Therapy for Liver Tumors. 2017; : 223 doi: 10.1007/978-3-319-54531-8_16
|
23 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_29-1
|
24 |
Rahul S. Koti, Brian R. Davidson. Sherlock's Diseases of the Liver and Biliary System. 2011; : 294 doi: 10.1002/9781444341294.ch13
|
25 |
Hong-Yang Li, Shi-Ji Zhou, Min Li, Ding Xiong, Akanand Singh, Qing-Xi Guo, Chang-An Liu, Jian-Ping Gong. Diagnosis and Cure Experience of Hepatolithiasis-Associated Intrahepatic Cholangiocarcinoma in 66 Patients. Asian Pacific Journal of Cancer Prevention 2012; 13(2): 725 doi: 10.7314/APJCP.2012.13.2.725
|
26 |
Xiao-Fang Liu, Hao Zhang, Shi-Guang Zhu, Xian-Ting Zhou, Hai-Long Su, Zheng Xu, Shao-Jun Li. Correlation of <i>p53</i> gene mutation and expression of P53 protein in cholangiocarcinoma. World Journal of Gastroenterology 2006; 12(29): 4706-4709 doi: 10.3748/wjg.v12.i29.4706
|
27 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 549 doi: 10.1007/978-3-319-26956-6_29
|
28 |
Botao Duan, Xuekai Zhao, Songsong Fan, Lei Zhou, Xingyuan Zhang. A rare case report of obstructive jaundice caused by mucus-producing cholangiocarcinoma. Medicine 2022; 101(3): e28478 doi: 10.1097/MD.0000000000028478
|
29 |
Roland W. W. Chong, Alexander Y. F. Chung, Ivy W. C. Chew, Victor K. M. Lee. Ruptured Peripheral Cholangiocarcinoma with Hemoperitoneum. Digestive Diseases and Sciences 2006; 51(5): 874 doi: 10.1007/s10620-006-9342-7
|
30 |
Tae Yoo, Sang-Jae Park, Sung-Sik Han, Seong Hoon Kim, Seung Duk Lee, Young-Kyu Kim, Tae Hyun Kim, Sang Myung Woo, Woo Jin Lee, Eun Kyung Hong. Postoperative CA19-9 Change Is a Useful Predictor of Intrahepatic Cholangiocarcinoma Survival following Liver Resection. Disease Markers 2015; 2015: 1 doi: 10.1155/2015/298985
|
31 |
Florence K. Keane, Andrew X. Zhu, Theodore S. Hong. Radiotherapy for Biliary Tract Cancers. Seminars in Radiation Oncology 2018; 28(4): 342 doi: 10.1016/j.semradonc.2018.06.003
|
32 |
Yu-Shi Dai, Hai-Jie Hu, Tian-run Lv, Ya-Fei Hu, Rui-Qi Zou, Fu-Yu Li. The influence of resection margin width in patients with intrahepatic cholangiocarcinoma: a meta-analysis. World Journal of Surgical Oncology 2023; 21(1) doi: 10.1186/s12957-023-02901-5
|
33 |
Xianwu Luo, Lei Yuan, Yi Wang, Ruiliang Ge, Yanfu Sun, Gongtian Wei. Survival Outcomes and Prognostic Factors of Surgical Therapy for All Potentially Resectable Intrahepatic Cholangiocarcinoma: a Large Single-Center Cohort Study. Journal of Gastrointestinal Surgery 2014; 18(3): 562 doi: 10.1007/s11605-013-2447-3
|
34 |
Stefania Mosconi, Giordano D. Beretta, Roberto Labianca, Maria G. Zampino, Gemma Gatta, Volker Heinemann. Cholangiocarcinoma. Critical Reviews in Oncology/Hematology 2009; 69(3): 259 doi: 10.1016/j.critrevonc.2008.09.008
|
35 |
Z.F. Wu, H.B. Zhang, N. Yang, W.C. Zhao, Y. Fu, G.S. Yang. Postoperative adjuvant transcatheter arterial chemoembolisation improves survival of intrahepatic cholangiocarcinoma patients with poor prognostic factors: Results of a large monocentric series. European Journal of Surgical Oncology (EJSO) 2012; 38(7): 602 doi: 10.1016/j.ejso.2012.02.185
|
36 |
Johan Fevery, Chris Verslype, Gillian Lai, Raymond Aerts, Werner Van Steenbergen. Incidence, Diagnosis, and Therapy of Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis. Digestive Diseases and Sciences 2007; 52(11): 3123 doi: 10.1007/s10620-006-9681-4
|
37 |
Kwang Yeol Paik, Jun Chul Jung, Jin Seok Heo, Seong Ho Choi, Dong Wook Choi, Yong Il Kim. What prognostic factors are important for resected intrahepatic cholangiocarcinoma?. Journal of Gastroenterology and Hepatology 2008; 23(5): 766 doi: 10.1111/j.1440-1746.2007.05040.x
|
38 |
Florence K. Keane, Theodore S. Hong. Intrahepatic Cholangiocarcinoma. 2019; : 151 doi: 10.1007/978-3-030-22258-1_11
|
39 |
C.-T. Chiu, J.-M. Chiang, T.-S. Yeh, J.-H. Tseng, T.-C. Chen, Y.-Y. Jan, M.-F. Chen. Clinicopathological analysis of colorectal cancer liver metastasis and intrahepatic cholangiocarcinoma: Are they just apples and oranges?. Digestive and Liver Disease 2008; 40(9): 749 doi: 10.1016/j.dld.2008.01.018
|
40 |
Parissa Tabrizian, Ghalib Jibara, Jaclyn F. Hechtman, Bernardo Franssen, Daniel M. Labow, Myron E. Schwartz, Swan N. Thung, Umut Sarpel. Outcomes following resection of intrahepatic cholangiocarcinoma. HPB 2015; 17(4): 344 doi: 10.1111/hpb.12359
|
41 |
Qian D. Zhu, Meng T. Zhou, Qing Q. Zhou, Hong Q. Shi, Qi Y. Zhang, Zheng P. Yu. Diagnosis and Surgical Treatment of Intrahepatic Hepatolithiasis Combined with Cholangiocarcinoma. World Journal of Surgery 2014; 38(8): 2097 doi: 10.1007/s00268-014-2476-4
|
42 |
Dietmar Tamandl, Beata Herberger, Birgit Gruenberger, Harald Puhalla, Markus Klinger, Thomas Gruenberger. Influence of Hepatic Resection Margin on Recurrence and Survival in Intrahepatic Cholangiocarcinoma. Annals of Surgical Oncology 2008; 15(10): 2787 doi: 10.1245/s10434-008-0081-1
|
43 |
Terence T. Sio, James A. Martenson, Michael G. Haddock, Paul J. Novotny, Gregory J. Gores, Steven R. Alberts, Robert C. Miller, Julie K. Heimbach, Charles B. Rosen. Outcome of Transplant-fallout Patients With Unresectable Cholangiocarcinoma. American Journal of Clinical Oncology 2016; 39(3): 271 doi: 10.1097/COC.0000000000000056
|
44 |
Seong Yeon Cho, Sang-Jae Park, Seong Hoon Kim, Sung-Sik Han, Young-Kyu Kim, Kwang-Woong Lee, Soon-Ae Lee, Eun Kyung Hong, Woo Jin Lee, Sang Myung Woo. Survival Analysis of Intrahepatic Cholangiocarcinoma After Resection. Annals of Surgical Oncology 2010; 17(7): 1823 doi: 10.1245/s10434-010-0938-y
|
45 |
Siobhan C. McKay, Kristian Unger, Stephanos Pericleous, Gordon Stamp, Gerry Thomas, Robert R. Hutchins, Duncan R.C. Spalding. Array comparative genomic hybridization identifies novel potential therapeutic targets in cholangiocarcinoma. HPB 2011; 13(5): 309 doi: 10.1111/j.1477-2574.2010.00286.x
|
46 |
Qiao Ke, Nanping Lin, Manjun Deng, Lei Wang, Yongyi Zeng, Jingfeng Liu, Gianfranco D. Alpini. The effect of adjuvant therapy for patients with intrahepatic cholangiocarcinoma after surgical resection: A systematic review and meta-analysis. PLOS ONE 2020; 15(2): e0229292 doi: 10.1371/journal.pone.0229292
|